|
A review of the device history record has been completed.No deviations or non-conformances noted.Device evaluation: based on the device analysis grid, the assessments of the complaint are: anxiety¿product/procedure: unable to observe since it is a medical event and is not related to the device.Depression: unable to observe as it is a medical event not related to the device.Seroma: unable to observe as it is a medical event not related to the device.Pain: unable to observe as it is a medical event not related to the device.Additional observations: deformation is observed.Yellow particles were observed on the shell.No further actions are required as the device was implanted.The event of seroma is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: seroma.
|
|
Patient reported left side exchange from textured to smooth due to concern with the product.Patient representative later reported plaintiff underwent painful removal procedures as well as treatment, therapy, recovery, and expense associated with the removal of the biocell textured breast implants due to fear of alcl, to reduce risk of alcl, and due to symptoms consistent with alcl and fear of alcl including: mental anguish, increased risk of alcl, evaluation for alcl, explant, reconstruction, seromas, physical pain, scarring and disfigurement.Additionally, plaintiff suffered aggravation of underlying conditions including emotional distress and anxiety, as well as loss of quality of life and depression; and other physical and emotional manifestations that are severe and ongoing.Plaintiff has not been diagnosed with bia-alcl.Device has been explanted.
|